These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database. Enrico A; Bestach Y; Flores MG; Arbelbide J; Serale C; Novoa V; Crisp R; Rivas MM; Larripa I; Belli C Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):743-752.e5. PubMed ID: 28797621 [TBL] [Abstract][Full Text] [Related]
63. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities. van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF; Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570 [TBL] [Abstract][Full Text] [Related]
64. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Kayser S; Zucknick M; Döhner K; Krauter J; Köhne CH; Horst HA; Held G; von Lilienfeld-Toal M; Wilhelm S; Rummel M; Germing U; Götze K; Nachbaur D; Schlegelberger B; Göhring G; Späth D; Morlok C; Teleanu V; Ganser A; Döhner H; Schlenk RF; Blood; 2012 Jan; 119(2):551-8. PubMed ID: 22096250 [TBL] [Abstract][Full Text] [Related]
65. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study. Kayser S; Hills RK; Langova R; Kramer M; Guijarro F; Sustkova Z; Estey EH; Shaw CM; Ráčil Z; Mayer J; Zak P; Baer MR; Brunner AM; Szotkowski T; Cetkovsky P; Grimwade D; Walter RB; Burnett AK; Ho AD; Ehninger G; Müller-Tidow C; Platzbecker U; Thiede C; Röllig C; Schulz A; Warsow G; Brors B; Esteve J; Russell NH; Schlenk RF; Levis MJ Br J Haematol; 2021 Mar; 192(5):832-842. PubMed ID: 33529373 [TBL] [Abstract][Full Text] [Related]
66. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Christiansen DH; Andersen MK; Pedersen-Bjergaard J Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781 [TBL] [Abstract][Full Text] [Related]
67. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia. Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183 [TBL] [Abstract][Full Text] [Related]
68. POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15). Lisboa S; Cerveira N; Bizarro S; Correia C; Vieira J; Torres L; Mariz JM; Teixeira MR Mol Cancer; 2013 Jan; 12():5. PubMed ID: 23332017 [TBL] [Abstract][Full Text] [Related]
69. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype. Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442 [TBL] [Abstract][Full Text] [Related]
70. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment. Fleischmann M; Schnetzke U; Schrenk KG; Schmidt V; Sayer HG; Hilgendorf I; Hochhaus A; Scholl S J Cancer Res Clin Oncol; 2017 Feb; 143(2):337-345. PubMed ID: 27778197 [TBL] [Abstract][Full Text] [Related]
71. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience. Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947 [TBL] [Abstract][Full Text] [Related]
72. Morphological characteristics, cytogenetic profile, and outcome of RUNX1-RUNX1T1-positive acute myeloid leukemia: Experience of an Indian tertiary care center. Gupta R; Yadav S; Parashar Y; Rahman K; Singh MK; Chandra D; Gupta A; Nityanand S Int J Lab Hematol; 2020 Feb; 42(1):37-45. PubMed ID: 31725954 [TBL] [Abstract][Full Text] [Related]
73. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia. Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602 [TBL] [Abstract][Full Text] [Related]
74. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases. Wu B; Ingersoll K; Jug R; Yang LH; Luedke C; Lo A; Su P; Liu X; Rehder C; Gong J; Lu CM; Wang E Am J Clin Pathol; 2017 Dec; 149(1):55-66. PubMed ID: 29228125 [TBL] [Abstract][Full Text] [Related]
75. [Clinical analysis of myeloid neoplasms with t (3;21) (q26;q22)]. Li Y; Liu Q; Wang Z; Qin YZ; Dang H; Shi Y; He Q; Jiang Q; Jiang H; Lai YY Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):195-199. PubMed ID: 30929385 [No Abstract] [Full Text] [Related]
76. Expression of NUP98/TOP1, but not of TOP1/NUP98, in a treatment-related myelodysplastic syndrome with t(10;20;11)(q24;q11;p15). Panagopoulos I; Fioretos T; Isaksson M; Larsson G; Billström R; Mitelman F; Johansson B Genes Chromosomes Cancer; 2002 Jun; 34(2):249-54. PubMed ID: 11979559 [TBL] [Abstract][Full Text] [Related]
77. [Molecular Characteristics and Clinical Features of Adults with Lun Y; Huang JC; Long D; Wang FF; Dai Y; Yang Y; Zhao TT; Li Q; Wu Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):575-581. PubMed ID: 30378313 [TBL] [Abstract][Full Text] [Related]
78. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients. Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848 [TBL] [Abstract][Full Text] [Related]
79. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830 [TBL] [Abstract][Full Text] [Related]
80. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial. Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]